RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
Clinical trials for RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemia: first human trial of KK2845 begins
Disease control Recruiting nowThis early-stage study tests a new drug called KK2845 for adults whose acute myeloid leukemia (AML) has returned or not improved after standard treatments. The goal is to find a safe dose and see how well the body tolerates it. About 72 participants will take part in two phases: …
Matched conditions: RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Supercharged immune cells take on resistant blood cancers
Disease control Recruiting nowThis study tests a new type of immune cell therapy for people with myeloid cancers (like AML or MDS) that have come back or not responded to treatment. The cells are taken from donated cord blood, engineered to better recognize and attack cancer cells, and given after chemotherap…
Matched conditions: RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC